Myriad Genetics Announces Eric Santa as Chief Growth Officer, Names New Diversity and Marketing Leaders
SALT LAKE CITY, March 29, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Eric Santa as its new Chief Growth Officer.
- SALT LAKE CITY, March 29, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Eric Santa as its new Chief Growth Officer.
- Santa, who reports directly to Paul J. Diaz, president and CEO of Myriad Genetics, brings proven healthcare expertise spanning consumer and digital businesses, as well as commercial transformation, portfolio management, and new growth channels.
- At Myriad, Santa will lead strategic initiatives that advance the companys growth plans, expand its reach, and drive customer-centric commercial capabilities across sales, marketing, and digital platforms.
- We are fortunate to have a senior executive of Erics caliber joining us to spearhead new growth initiatives together with proven marketing leaders like Jeff.